reference/18687076

http://rdf.ncbi.nlm.nih.gov/pubchem/reference/18687076

Outgoing Links

Predicate	Object
contentType	Clinical Trial, Phase II\|Journal Article\|Multicenter Study\|Research Support, N.I.H., Extramural\|Research Support, Non-U.S. Gov't
endingPage	3718
issn	0732-183X 1527-7755
issueIdentifier	24
pageRange	3712-3718
publicationName	Journal of clinical oncology : official journal of the American Society of Clinical Oncology
startingPage	3712
hasFundingAgency	http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_b5ad88fdb9d8a30d34a9b7f844c05af4
isSupportedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/grant/MD5_c5e300a229d5a98ee18aace9cb4ce67f
bibliographicCitation	Zhang W, Gordon M, Schultheis AM, Yang DY, Nagashima F, Azuma M, Chang HM, Borucka E, Lurje G, Sherrod AE, Iqbal S, Groshen S, Lenz HJ. FCGR2A and FCGR3A polymorphisms associated with clinical outcome of epidermal growth factor receptor expressing metastatic colorectal cancer patients treated with single-agent cetuximab. J Clin Oncol. 2007 Aug 20;25(24):3712–8. doi: 10.1200/jco.2006.08.8021. PMID: 17704420.
creator	http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c85860093a23f4782ced99ab13ffaea9 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_f480d89c447e0ea10cad608b9c5be3b2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_584596b1c3e21920427b5a85e56f75e2 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_8cfc9e79c00d0e4b2d315d3d23e08d83 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2c4d54966115c87b6dd13a6cddb0f713 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c7510efc4c90a96913bac1df77efb3e5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_b32733e707a9a0a8a31abd2d42a54af3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c335bc5c7b206a952ef4ea8c307a7ec3 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d4ba35442b03ea65de00f905f6bd5891 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_10b6fe1da57f2d5fd0f0d337e2589879 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cb2dd722f07ff43286fb8dec893022f5 http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cf5da0dde370cca9b807edcc506d8c0d http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_c973d0f6b6d00b2975c75789f24012c7
date	2007-08-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
identifier	https://doi.org/10.1200/jco.2006.08.8021 https://pubmed.ncbi.nlm.nih.gov/17704420
isPartOf	http://rdf.ncbi.nlm.nih.gov/pubchem/journal/5023 https://portal.issn.org/resource/ISSN/1527-7755 https://portal.issn.org/resource/ISSN/0732-183X
language	English
source	https://pubmed.ncbi.nlm.nih.gov/ https://www.crossref.org/
title	FCGR2A and FCGR3A Polymorphisms Associated With Clinical Outcome of Epidermal Growth Factor Receptor–Expressing Metastatic Colorectal Cancer Patients Treated With Single-Agent Cetuximab
discusses	http://id.nlm.nih.gov/mesh/M0593322 http://id.nlm.nih.gov/mesh/M0422675 http://id.nlm.nih.gov/mesh/M0480489 http://id.nlm.nih.gov/mesh/M0001357 http://id.nlm.nih.gov/mesh/M0556300 http://id.nlm.nih.gov/mesh/M0001483 http://id.nlm.nih.gov/mesh/M0412785 http://id.nlm.nih.gov/mesh/M0026482
hasPrimarySubjectTerm	http://id.nlm.nih.gov/mesh/D011110 http://id.nlm.nih.gov/mesh/D000970Q000627 http://id.nlm.nih.gov/mesh/D000911Q000627 http://id.nlm.nih.gov/mesh/D015179Q000188 http://id.nlm.nih.gov/mesh/D017452Q000235
hasSubjectTerm	http://id.nlm.nih.gov/mesh/D000369 http://id.nlm.nih.gov/mesh/D006801 http://id.nlm.nih.gov/mesh/D000368 http://id.nlm.nih.gov/mesh/D015996 http://id.nlm.nih.gov/mesh/D005260 http://id.nlm.nih.gov/mesh/D008297 http://id.nlm.nih.gov/mesh/D000970Q000009 http://id.nlm.nih.gov/mesh/D005838 http://id.nlm.nih.gov/mesh/D066246Q000378 http://id.nlm.nih.gov/mesh/D000911Q000009 http://id.nlm.nih.gov/mesh/D008875 http://id.nlm.nih.gov/mesh/D015179Q000235 http://id.nlm.nih.gov/mesh/D015179Q000473 http://id.nlm.nih.gov/mesh/D015179Q000401 http://id.nlm.nih.gov/mesh/D000920 http://id.nlm.nih.gov/mesh/D061067 http://id.nlm.nih.gov/mesh/D018572 http://id.nlm.nih.gov/mesh/D000328 http://id.nlm.nih.gov/mesh/D000068818
discussesAsDerivedByTextMining	http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8603 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID8389 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6140 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6287 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_5b880aeb5b282a0777eece1691337793 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_9a784dff46ed44d6c0b5f4ad7f906f62 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID108157 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/MD5_fddb60309b0ee16f8cd57b4b90c99e89 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6274 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID11449 http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6322 http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID9672

Incoming Links

Predicate	Subject
isDiscussedBy	http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2214 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128458032 http://rdf.ncbi.nlm.nih.gov/pubchem/gene/GID2212 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID128084797 http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID127654813

Total number of triples: 83.